SCHEMBL23787472

SCHEMBL23787472

COc1ccc2c(=O)c3cc(OC)c(OC)cc3sc2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.60
RAB9A P51151 4/20 0.60
MAPT P10636 4/20 0.60
KDM4E B2RXH2 3/20 0.60
ALDH1A1 P00352 3/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
TDP1 Q9NUW8 1/20 0.60
HPGD P15428 1/20 0.47
CASP3 P42574 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
UHRF1 Q96T88 1/20 0.46
PRNP P04156 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
PPARG P37231 1/20 0.46
HTT P42858 1/20 0.46
MAPK10 P53779 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31676786 0.90 NPC1 (0.69) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL21624241 0.90 NPC1 (0.69) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL30017661 0.90 KDM4E (0.67) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL13338880 0.90 KDM4E (0.67) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL31676772 0.82 NPC1 (0.67) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL21624244 0.82 NPC1 (0.67) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL30612325 0.82 ALDH1A1 (0.82) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL4481328 0.82 ALDH1A1 (0.82) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL31037131 0.82 ALDH1A1 (0.82) NPC1RAB9AMAPTKDM4EALDH1A1
SCHEMBL3962337 0.81 SERPINE1 (0.46) NPC1RAB9AMAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210277017-A1 Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition LINTFIELD LIMITED (GB) 2021-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210277017-A1 Thioxanthone Derivatives, Composition Comprising the Same and Pattern Forming Method Comprising Said Composition TPMT, TST, PPOX NPC1 2592/4885RAB9A 3603/4885MAPT 410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.